[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.150.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 261
Citations 0
Comment & Response
December 2013

Next-Generation Phenotyping and Genomic Incidental FindingsBeyond the Parkin Example

Author Affiliations
  • 1Department of Neurology and Psychiatry, Memory Clinic, University Sapienza, Rome, Italy
  • 2INSERM UMR 1027, Université de Toulouse III, Paul Sabatier, Faculté de Médicine, Toulouse, France
JAMA Neurol. 2013;70(12):1589. doi:10.1001/jamaneurol.2013.4521

To the Editor A recent study1 in JAMA Neurology advanced the notion of next-generation phenotyping. Grünewald et al1 systematically evaluated the quality of published genetic and phenotypic data concerning parkin-associated Parkinson disease cases by adopting an ad-hoc score combining both genetic and clinical criteria. Interestingly, they found that while the quality of genetic analyses continuously increased over the last 15 years, the quality of retained clinical data stayed stable over time. Therefore, they proposed mandatory minimal criteria aimed at improving data acquisition and reporting in genotype-phenotype correlation studies. This is of crucial interest in both research and clinical settings in neurology as well as in all other medical domains.

First Page Preview View Large
First page PDF preview
First page PDF preview
×